Law MG - Search Results

1

Influence of IFNgamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy.

Emery S, Kelleher AD, Workman C, Puls RL, Bloch M, Baker D, Anderson J, Hoy J, Ip S, Nalliah K, Ward LD, Law MG, Cooper DA. Emery S, et al. Among authors: law mg. Hum Vaccin. 2007 Nov-Dec;3(6):260-7. doi: 10.4161/hv.4627. Epub 2007 Jun 25. Hum Vaccin. 2007. PMID: 18340117

2

Changes in biologic phenotype of human immunodeficiency virus during treatment of patients with didanosine.

Zheng NN, McQueen PW, Hurren L, Evans LA, Law MG, Forde S, Barker S, Cooper DA, Delaney SF. Zheng NN, et al. Among authors: law mg. J Infect Dis. 1996 May;173(5):1092-6. doi: 10.1093/infdis/173.5.1092. J Infect Dis. 1996. PMID: 8627059 Clinical Trial.

3

Incidence of HIV infection in a cohort of homosexually active men.

McNulty A, Law MG, Bodsworth NJ, Cooper DA, Kaldor JM. McNulty A, et al. Among authors: law mg. Aust N Z J Public Health. 1997 Oct;21(6):587-9. doi: 10.1111/j.1467-842x.1997.tb01760.x. Aust N Z J Public Health. 1997. PMID: 9470263 Free article.

4

HIV disease progression in Australia in the time of combination antiretroviral therapies.

Correll PK, Law MG, McDonald AM, Cooper DA, Kaldor JM. Correll PK, et al. Among authors: law mg. Med J Aust. 1998 Nov 2;169(9):469-72. Med J Aust. 1998. PMID: 9847898

5

AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment.

Law MG, de Winter L, McDonald A, Cooper DA, Kaldor JM. Law MG, et al. AIDS. 1999 Feb 4;13(2):263-9. doi: 10.1097/00002030-199902040-00015. AIDS. 1999. PMID: 10202833

6

B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS.

Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ, Gold J, Finlayson RJ, Cooper DA, Kaldor JM. Grulich AE, et al. Among authors: law mg. AIDS. 2000 Jan 28;14(2):133-40. doi: 10.1097/00002030-200001280-00008. AIDS. 2000. PMID: 10708283

7

Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection.

Law MG, Li Y, McDonald AM, Cooper DA, Kaldor JM. Law MG, et al. AIDS. 2000 Jan 28;14(2):197-201. doi: 10.1097/00002030-200001280-00016. AIDS. 2000. PMID: 10708291

8

Capturing the paradigm shift in HIV treatment: changing attitudes in the choice of combination antiretroviral drugs by high HIV caseload Australian GPs (1996-1997).

Smith D, Goggin L, Meldrum H, Phillips S, Russell D, Bloch M, Bodsworth NJ, Roth N, Law MG. Smith D, et al. Among authors: law mg. AIDS Care. 2000 Feb;12(1):41-7. doi: 10.1080/09540120047459. AIDS Care. 2000. PMID: 10716016

9

Lipodystrophy following antiretroviral therapy of primary HIV infection.

Miller J, Carr A, Smith D, Emery S, Law MG, Grey P, Cooper DA. Miller J, et al. Among authors: law mg. AIDS. 2000 Oct 20;14(15):2406-7. doi: 10.1097/00002030-200010200-00025. AIDS. 2000. PMID: 11089632 No abstract available.

10

Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy.

Grulich AE, Li Y, McDonald AM, Correll PK, Law MG, Kaldor JM. Grulich AE, et al. Among authors: law mg. AIDS. 2001 Mar 30;15(5):629-33. doi: 10.1097/00002030-200103300-00013. AIDS. 2001. PMID: 11317001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

300 results

Search Page

Filters